Alnylam Pharmaceuticals, Inc. (ALNY)
232.68
+8.15
(+3.63%)
USD |
NASDAQ |
Oct 09, 16:00
233.00
+0.32
(+0.14%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price to Book Value : 22.98 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 22.98 |
| October 08, 2026 | 22.17 |
| October 07, 2026 | 22.16 |
| October 06, 2026 | 22.12 |
| October 05, 2026 | 21.72 |
| October 02, 2026 | 21.70 |
| October 01, 2026 | 22.83 |
| September 30, 2026 | 24.37 |
| September 29, 2026 | 25.09 |
| September 28, 2026 | 25.22 |
| September 25, 2026 | 25.28 |
| September 24, 2026 | 24.65 |
| September 23, 2026 | 24.35 |
| September 22, 2026 | 24.85 |
| September 21, 2026 | 24.13 |
| September 18, 2026 | 23.66 |
| September 17, 2026 | 24.25 |
| September 16, 2026 | 23.64 |
| September 15, 2026 | 23.53 |
| September 14, 2026 | 24.69 |
| September 11, 2026 | 24.56 |
| September 10, 2026 | 24.44 |
| September 09, 2026 | 25.48 |
| September 08, 2026 | 25.69 |
| September 04, 2026 | 26.28 |
| Date | Value |
|---|---|
| September 03, 2026 | 26.12 |
| September 02, 2026 | 26.41 |
| September 01, 2026 | 24.31 |
| August 31, 2026 | 23.77 |
| August 28, 2026 | 23.42 |
| August 27, 2026 | 23.36 |
| August 26, 2026 | 23.60 |
| August 25, 2026 | 23.71 |
| August 24, 2026 | 23.31 |
| August 21, 2026 | 23.33 |
| August 20, 2026 | 22.65 |
| August 19, 2026 | 23.96 |
| August 18, 2026 | 22.58 |
| August 17, 2026 | 22.18 |
| August 14, 2026 | 22.58 |
| August 13, 2026 | 22.43 |
| August 12, 2026 | 22.12 |
| August 11, 2026 | 21.85 |
| August 10, 2026 | 21.43 |
| August 07, 2026 | 21.65 |
| August 06, 2026 | 21.34 |
| August 05, 2026 | 22.59 |
| August 04, 2026 | 21.63 |
| August 03, 2026 | 21.76 |
| July 31, 2026 | 20.30 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 17.06 |
| BridgeBio Pharma, Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 2.434 |
| Vertex Pharmaceuticals, Inc. | 6.382 |
| Pfizer Inc. | 1.892 |
Price to Book Value Related Metrics
| PE Ratio | 39.28 |
| PS Ratio | 6.661 |
| Price to Free Cash Flow | 40.31 |
| Price | 232.68 |
| Earnings Yield | 2.55% |
| Market Cap | 31.12B |
| Operating PE Ratio | 32.01 |
| Normalized PE Ratio | 40.42 |